Comparison of XXXX versus @entity3371 in high blood pressure: a randomized controlled trial.

@entity1 @entity341 @entity3371 @entity148 @entity1401
OBJECTIVE. @entity148 is an important cause of acute blood pressure (BP) elevation. However, the role of anxiolysis in this situation is still controversial. In this study, the relationship of @entity148 with BP and the effect of anxiolytic treatment on BP were investigated. METHODS. @entity341 ( @entity341 ) @entity1 with an initial systolic BP (SBP) >=  160 mmHg or diastolic BP (DBP) >=  100 mmHg but no end organ damage were approached for inclusion in the study. In those consenting to participate, @entity148 levels were measured using the State-Trait @entity148 Index (STAI) and Visual Analog Scale for @entity148 (VAS-A). @entity1 were randomly assigned to receive oral @entity1401 0.5 mg or @entity3371 25 mg. BP and @entity148 levels were measured at baseline and at 1 and 2 h after administration of the study medication. RESULTS. Of 133 @entity1 meeting inclusion criteria, 53 @entity1 agreed to participate. Of these, 27 @entity1 (50.9%) received @entity3371 and 26 @entity1 (49.1%) received @entity1401 . The majority of the @entity1 had a high-level trait (96.2%, n = 51) and state @entity148 (81.1%, n = 43). The mean SBP and VAS-A values of both @entity1 groups dropped significantly over the 2 h, with no significant difference between the two groups. A significant association between SBP and VAS-A scores was found (F((2,50)) = 6.27, p = 0.004). CONCLUSION: A significant association exists between the level of BP and @entity148 in hypertensive @entity341 @entity1 . @entity1401 is as effective as @entity3371 in lowering BP in @entity341 @entity1 with an initial SBP > 160 mmHg.
